Garlic essential oil protects against obesity-triggered nonalcoholic fatty liver disease through modulation of lipid metabolism and oxidative stress

Journal of Agricultural and Food Chemistry

Volumn 62, Issue 25, 2014, Pages 5897-5906

  Lai, Yi Syuan ^a   Chen, Wei Cheng ^a   Ho, Chi Tang ^a,b   Lu, Kuan Hung ^a   Lin, Shih Hang ^a   Tseng, Hui Chun ^a   Lin, Shuw Yuan ^c   Sheen, Lee Yan ^a,d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b RUTGERS UNIVERSITY   (United States)

^c HUNGKUANG UNIVERSITY   (Taiwan)

^d Section 4   (Taiwan)

Author keywords

diallyl disulfide; garlic essential oil; lipid metabolism; nonalcoholic fatty liver disease; oxidative stress

Indexed keywords

CYTOLOGY; MAMMALS; METABOLISM; NUTRITION; OXIDATIVE STRESS; PHYSIOLOGY; SULFUR COMPOUNDS; WELL STIMULATION; FATTY ACIDS; OIL SHALE; ORBITS;

ACETYL-COA CARBOXYLASE; BIOCHEMICAL PARAMETERS; DIALLYL DISULFIDE; LIPID METABOLISMS; NON-ALCOHOLIC FATTY LIVER DISEASE; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PRO-INFLAMMATORY CYTOKINES; STEROL REGULATORY ELEMENTS; CARNITINE PALMITOYLTRANSFERASE; STEROL REGULATORY ELEMENT-BINDING PROTEINS;

ESSENTIAL OILS;

ALLIUM SATIVUM; MUS;

3-HYDROXY-3-METHYLGLUTARYL-COENZYME A; ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A; ESSENTIAL OIL; PROTECTIVE AGENT; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; VEGETABLE OIL;

ANIMAL; C57BL MOUSE; CHEMISTRY; COMPLICATION; DRUG EFFECTS; ENZYMOLOGY; GARLIC; GENETICS; HUMAN; LIPID METABOLISM; MALE; METABOLISM; MOUSE; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; OXIDATIVE STRESS;

ACETYL-COA CARBOXYLASE; ACYL COENZYME A; ANIMALS; GARLIC; HUMANS; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; OILS, VOLATILE; OXIDATIVE STRESS; PLANT OILS; PROTECTIVE AGENTS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 84903288631     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf500803c     Document Type: Article

References (37)

1. Machado, M.; Cortez-Pinto, H. Non-alcoholic steatohepatitis and metabolic syndrome Curr. Opin. Clin. Nutr. Metab. Care 2006, 9, 637-642
2. Ahmed, M. H.; Abu, E. O.; Byrne, C. D. Non-alcoholic fatty liver disease (NAFLD): new challenge for general practitioners and important burden for health authorities? Prim. Care Diabetes 2010, 4, 129-137
3. Krawczyk, M.; Bonfrate, L.; Portincasa, P. Nonalcoholic fatty liver disease Best Pract. Res. Clin. Gastroenterol. 2010, 24, 695-708
4. Malaguarnera, M.; Di Rosa, M.; Nicoletti, F.; Malaguarnera, L. Molecular mechanisms involved in NAFLD progression J. Mol. Med. (Berlin) 2009, 87, 679-695
5. Rahimi, R. S.; Landaverde, C. Nonalcoholic fatty liver disease and the metabolic syndrome: clinical implications and treatment Nutr. Clin. Pract. 2013, 28, 40-51
6. Serviddio, G.; Bellanti, F.; Vendemiale, G. Free radical biology for medicine: learning from nonalcoholic fatty liver disease Free Radical Biol. Med. 2013, 65, 952-968
7. Shimano, H.; Yahagi, N.; Amemiya-Kudo, M.; Hasty, A. H.; Osuga, J.; Tamura, Y.; Shionoiri, F.; Iizuka, Y.; Ohashi, K.; Harada, K.; Gotoda, T.; Ishibashi, S.; Yamada, N. Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes J. Biol. Chem. 1999, 274, 35832-35839
8. Reddy, J. K.; Hashimoto, T. Peroxisomal β-oxidation and peroxisome proliferator-activated receptor α: an adaptive metabolic system Annu. Rev. Nutr. 2001, 21, 193-230
9. Prompila, N.; Wittayalertpanya, S.; Komolmit, P. Hepatic cytochrome P450 2E1 activity in nonalcoholic fatty liver disease J. Med. Assoc. Thai. 2008, 91, 733-738
10. Amagase, H.; Petesch, B. L.; Matsuura, H.; Kasuga, S.; Itakura, Y. Intake of garlic and its bioactive components J. Nutr. 2001, 131, 955S-962S
11. Amagase, H. Clarifying the real bioactive constituents of garlic J. Nutr. 2006, 136, 716S-725S
12. Banerjee, S. K.; Mukherjee, P. K.; Maulik, S. K. Garlic as an antioxidant: the good, the bad and the ugly Phytother. Res. 2003, 17, 97-106
13. Fujisawa, H.; Watanabe, K.; Suma, K.; Origuchi, K.; Matsufuji, H.; Seki, T.; Ariga, T. Antibacterial potential of garlic-derived allicin and its cancellation by sulfhydryl compounds Biosci., Biotechnol., Biochem. 2009, 73, 1948-1955
14. Jalal, R.; Bagheri, S. M.; Moghimi, A.; Rasuli, M. B. Hypoglycemic effect of aqueous shallot and garlic extracts in rats with fructose-induced insulin resistance J. Clin. Biochem. Nutr. 2007, 41, 218-223
15. Lee, M. S.; Kim, I. H.; Kim, C. T.; Kim, Y. Reduction of body weight by dietary garlic is associated with an increase in uncoupling protein mRNA expression and activation of AMP-activated protein kinase in diet-induced obese mice J. Nutr. 2011, 141, 1947-1953
16. Xiao, J.; Guo, R.; Fung, M. L.; Liong, E. C.; Chang, R. C.; Ching, Y. P.; Tipoe, G. L. Garlic-derived S-allylmercaptocysteine ameliorates nonalcoholic fatty liver disease in a rat model through inhibition of apoptosis and enhancing autophagy Evidence-Based Complement. Altern. Med. 2013, 2013, 642920
17. Chu, Y. L.; Raghu, R.; Lu, K. H.; Liu, C. T.; Lin, S. H.; Lai, Y. S.; Cheng, W. C.; Lin, S. H.; Sheen, L. Y. Autophagy therapeutic potential of garlic in human cancer therapy J. Tradit. Complement. Med. 2013, 3, 159-162
18. Sheen, L. Y.; Chen, H. W.; Kung, Y. L.; Liu, C. T.; Lii, C. K. Effects of garlic oil and its organosulfur compounds on the activities of hepatic drug-metabolizing and antioxidant enzymes in rats fed high- and low-fat diets Nutr. Cancer 1999, 35, 160-166
19. Zeng, T.; Guo, F. F.; Zhang, C. L.; Zhao, S.; Dou, D. D.; Gao, X. C.; Xie, K. Q. The anti-fatty liver effects of garlic oil on acute ethanol-exposed mice Chem.-Biol. Interact. 2008, 176, 234-242
20. Zeng, T.; Zhang, C. L.; Song, F. Y.; Zhao, X. L.; Xie, K. Q. Garlic oil alleviated ethanol-induced fat accumulation via modulation of SREBP-1, PPAR-α, and CYP2E1 Food Chem. Toxicol. 2012, 50, 485-491
21. Sheen, L. Y.; Lin, S. Y.; Tsi, S. J. Odor assessments for volatile compounds of garlic and ginger essential oils by sniffing method of gas chromatography J. Chin. Agric. Chem. Soc. 1992, 30, 14-24
22. Banerjee, S. K.; Maulik, S. K. Effect of garlic on cardiovascular disorders: a review Nutr. J. 2002, 1, 4
23. Takahashi, Y.; Soejima, Y.; Fukusato, T. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis World J. Gastroenterol. 2012, 18, 2300-2308
24. Kang, J. S.; Lee, W. K.; Lee, C. W.; Yoon, W. K.; Kim, N.; Park, S. K.; Lee, H. S.; Park, H. K.; Han, S. B.; Yun, J.; Lee, K.; Lee, K. H.; Park, S. K.; Kim, H. M. Improvement of high-fat diet-induced obesity by a mixture of red grape extract, soy isoflavone and l -carnitine: implications in cardiovascular and non-alcoholic fatty liver diseases Food Chem. Toxicol. 2011, 49, 2453-2458
25. Tzeng, T. F.; Lu, H. J.; Liou, S. S.; Chang, C. J.; Liu, I. M. Cassia tora (Leguminosae) seed extract alleviates high-fat diet-induced nonalcoholic fatty liver Food Chem. Toxicol. 2013, 51, 194-201
26. Fromenty, B.; Robin, M. A.; Igoudjil, A.; Mansouri, A.; Pessayre, D. The ins and outs of mitochondrial dysfunction in NASH Diabetes Metab. 2004, 30, 121-138
27. Kim, I.; Kim, H. R.; Kim, J. H.; Om, A. S. Beneficial effects of Allium sativum L. stem extract on lipid metabolism and antioxidant status in obese mice fed a high-fat diet J. Sci. Food Agric. 2013, 93, 2749-2757
28. Supakul, L.; Pintana, H.; Apaijai, N.; Chattipakorn, S.; Shinlapawittayatorn, K.; Chattipakorn, N. Protective effects of garlic extract on cardiac function, heart rate variability, and cardiac mitochondria in obese insulin-resistant rats Eur. J. Nutr. 2013, 10.1001/s00394-013-0595-6
29. Kohjima, M.; Higuchi, N.; Kato, M.; Kotoh, K.; Yoshimoto, T.; Fujino, T.; Yada, M.; Yada, R.; Harada, N.; Enjoji, M.; Takayanagi, R.; Nakamuta, M. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease Int. J. Mol. Med. 2008, 21, 507-511
30. Pan, M. H.; Lai, C. S.; Tsai, M. L.; Ho, C. T. Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds Mol. Nutr. Food Res. 2014, 58, 147-171
31. Browning, J. D.; Horton, J. D. Molecular mediators of hepatic steatosis and liver injury J. Clin. Invest. 2004, 114, 147-152
32. Robertson, G.; Leclercq, I.; Farrell, G. C. Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 281, G1135-G1139
33. Lee, H. I.; Yun, K. W.; Seo, K. I.; Kim, M. J.; Lee, M. K. Scopoletin prevents alcohol-induced hepatic lipid accumulation by modulating the AMPK-SREBP pathway in diet-induced obese mice Metabolism 2014, 63, 593-601
34. Xiao, J.; Ching, Y. P.; Liong, E. C.; Nanji, A. A.; Fung, M. L.; Tipoe, G. L. Garlic-derived S-allylmercaptocysteine is a hepato-protective agent in non-alcoholic fatty liver disease in vivo animal model Eur. J. Nutr. 2013, 52, 179-191
35. Han, C. Y.; Ki, S. H.; Kim, Y. W.; Noh, K.; Lee da, Y.; Kang, B.; Ryu, J. H.; Jeon, R.; Kim, E. H.; Hwang, S. J.; Kim, S. G. Ajoene, a stable garlic by-product, inhibits high fat diet-induced hepatic steatosis and oxidative injury through LKB1-dependent AMPK activation Antioxid. Redox. Signal. 2011, 14, 187-202
36. Shimada, M.; Liu, L.; Nussler, N.; Jonas, S.; Langrehr, J. M.; Ogawa, T.; Kaminishi, M.; Neuhaus, P.; Nussler, A. K. Human hepatocytes are protected from ethanol-induced cytotoxicity by DADS via CYP2E1 inhibition Toxicol. Lett. 2006, 163, 242-249
37. Wu, C. C.; Sheen, L. Y.; Chen, H. W.; Kuo, W. W.; Tsai, S. J.; Lii, C. K. Differential effects of garlic oil and its three major organosulfur components on the hepatic detoxification system in rats J. Agric. Food Chem. 2002, 50, 378-383